(Q24235807)

3

0 references

author name string

Michelle van der Linden

1

0 references

Karen Buckingham

2

0 references

Jan AM Kremer

4

0 references

Mostafa Metwally

Cochrane Database of Systematic Reviews

5

0 references

language of work or name

English

0 references

publication date

5 October 2011

0 references

published in

0 references

issue

10

0 references

page(s)

CD009154

0 references

cites work

Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Does luteal estradiol supplementation have a role in long agonist cycles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of <or=7 mm on day of egg retrieval

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Salivary and serum progesterone concentrations during two luteal support regimens used in in vitro fertilization treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone--impact of luteal estrogen: prospective, randomized study and post hoc analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparison of Crinone 8% intravaginal gel and intramuscular progesterone for luteal support in in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal support: progestogens for pregnancy protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Experience with a novel vaginal progesterone preparation in a donor oocyte program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal support for IVF/ICSI cycles with Crinone 8% (90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression--a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal phase support in assisted reproductive technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Human chorionic gonadotrophin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilization and embryo transfer programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

Luteal phase support in assisted reproduction cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009154.PUB2

10.1002/14651858.CD009154.PUB2

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

21975790

1 reference

Consolidated OpenCitations Corpus – April 2017